NEW YORK , Nov. 11, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global veterinary artificial insemination market size is estimated to grow by USD 962.3 million from 2024-2028, according to Technavio.
The market is estimated to grow at a CAGR of 5.21% during the forecast period. Increasing demand for livestock multiplication is driving market growth, with a trend towards increase in government initiatives for veterinary artificial insemination.
However, high cost of equipment and procedures in veterinary artificial insemination poses a challenge.Key market players include Agtech Inc., Bovine Elite LLC, Cooperatie Koninklijke CRV u.
a., Covetrus Inc., Genus Plc, Hamilton Thorne Ltd, IMV Technologies, Inguran LLC, Jorgensen Laboratories LLC, Mai Animal Health, Merck and Co.
Inc., Neogen Corp., PBS Animal Health and Horse Health USA , Santa Cruz Biotechnology Inc.
, Select Sires Inc., Swine Genetics International, URUS Group LP, VikingGenetics F.M.
B.A, Zhengzhou Zhimuren Machinery Equipment Co., and Zoetis Inc.
. Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF Market Driver The global veterinary artificial insemination market is experiencing growth due to increasing government initiatives.
These initiatives aim to enhance livestock genetics, boost productivity, and mitigate the spread of animal diseases. Traditional farming methods are insufficient to meet the rising de.
